UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 311

Sortiert nach

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

The New England journal of medicine, 2013-02, Vol.368 (6), p.513-523

2013

Volltextzugriff (PDF)

New paradigms in venous thromboprophylaxis of medically ill patients

Thrombosis and haemostasis, 2017, Vol.117 (9), p.1662

2017

Volltextzugriff (PDF)

A Review of FXIa Inhibition as a Novel Target for Anticoagulation

Hamostaseologie, 2023-02, Vol.43 (1), p.28

2023

Volltextzugriff (PDF)

Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients

Thrombosis and haemostasis, 2021-08, Vol.121 (8), p.1043

2021

Volltextzugriff (PDF)

Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis

Blood, 2020-05, Vol.135 (20), p.1788-1810

2020

Volltextzugriff (PDF)

Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2022-10, Vol.20 (10), p.2226-2236

2022

Volltextzugriff (PDF)

Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients

The American journal of medicine, 2016-09, Vol.129 (9), p.1001.e9-1001.e18

2016

Volltextzugriff (PDF)

External Validation of the Risk Assessment Model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for Medical Patients in a Tertiary Health System

Journal of the American Heart Association, 2014-11, Vol.3 (6), p.e001152-n/a

2014

Volltextzugriff (PDF)

System-Wide Thromboprophylaxis Interventions for Hospitalized Patients at Risk of Venous Thromboembolism: Focus on Cross-Platform Clinical Decision Support

Journal of clinical medicine, 2024-04, Vol.13 (7), p.2133

2024

Volltextzugriff (PDF)

Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?

International journal of hematology, 2021-03, Vol.113 (3), p.330-336

2021

Volltextzugriff (PDF)

Emergence of institutional antithrombotic protocols for coronavirus 2019

Research and practice in thrombosis and haemostasis, 2020-05, Vol.4 (4), p.510-517

2020

Volltextzugriff (PDF)

Direct oral anticoagulants in the treatment of pulmonary embolism

Current medical research and opinion, 2018-01, Vol.34 (1), p.131-140

2018

Volltextzugriff (PDF)

New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients

Journal of clinical medicine, 2020-04, Vol.9 (4), p.1002

2020

Volltextzugriff (PDF)

Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study

Journal of the American Heart Association, 2020-10, Vol.9 (19), p.e017316

2020

Volltextzugriff (PDF)

Implementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis

Clinical and applied thrombosis/hemostasis, 2023-01, Vol.29, p.10760296231154553-10760296231154553

2023

Volltextzugriff (PDF)

To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients

Hematology, 2022-12, Vol.2022 (1), p.506

Spyropoulos, Alex C

2022

Volltextzugriff (PDF)

Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19

Journal of thrombosis and haemostasis, 2020-08, Vol.18 (8), p.1859-1865

2020

Volltextzugriff (PDF)

Rates of venous thromboembolism occurrence in medical patients among the insured population

Thrombosis and haemostasis, 2009-11, Vol.102 (5), p.951

2009

Volltextzugriff (PDF)

How I treat anticoagulated patients undergoing an elective procedure or surgery

Blood, 2012-10, Vol.120 (15), p.2954-2962

2012

Volltextzugriff (PDF)

Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed

The American journal of medicine, 2016-11, Vol.129 (11), p.S54-S63

2016

Volltextzugriff (PDF)

Thromboprophylaxis in critical care

Intensive care medicine, 2023-01, Vol.49 (1), p.75-78

2023

Volltextzugriff (PDF)

Venous thromboembolism following hematopoietic stem cell transplantation—a systematic review and meta-analysis

Annals of Hematology, 2016-09, Vol.95 (9), p.1457-1464

2016

Volltextzugriff (PDF)

Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study

Clinical and applied thrombosis/hemostasis, 2019, Vol.25, p.1076029619886022-1076029619886022

2019

Volltextzugriff (PDF)

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

Journal of the American Heart Association, 2021-03, Vol.10 (5), p.e019459-e019459

2021

Volltextzugriff (PDF)

Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds

Clinical and applied thrombosis/hemostasis, 2022, Vol.28, p.107602962211105-10760296221110568

2022

Volltextzugriff (PDF)

1 – 25 von 311

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(294)
Mit Volltextzugriff
(258)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(196)
Science & Technology
(196)
Humans
(187)
Cardiovascular System & Cardiology
(101)
Hematology
(97)
Peripheral Vascular Disease
(89)
Anticoagulants
(75)
Risk Factors
(74)
Anticoagulants - Therapeutic Use
(71)
Female
(71)
Male
(69)
Venous Thromboembolism
(69)
Thromboembolism
(59)
Thrombosis
(58)
Aged
(57)
Anticoagulants - Adverse Effects
(54)
Middle Aged
(51)
General & Internal Medicine
(47)
Hospitalization
(47)
Anticoagulants - Administration & Dosage
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients

New paradigms in venous thromboprophylaxis of medically ill patients

A Review of FXIa Inhibition as a Novel Target for Anticoagulation

Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients

Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis

Good practice statements for antithrombotic therapy in the management of COVID‐19: Guidance from the SSC of the ISTH

Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients

External Validation of the Risk Assessment Model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for Medical Patients in a Tertiary Health System

System-Wide Thromboprophylaxis Interventions for Hospitalized Patients at Risk of Venous Thromboembolism: Focus on Cross-Platform Clinical Decision Support

Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?

Emergence of institutional antithrombotic protocols for coronavirus 2019

Direct oral anticoagulants in the treatment of pulmonary embolism

New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients

Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study

Implementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis

To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients

Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19

Rates of venous thromboembolism occurrence in medical patients among the insured population

How I treat anticoagulated patients undergoing an elective procedure or surgery

Re-Initiation of Dabigatran and Direct Factor Xa Antagonists After a Major Bleed

Thromboprophylaxis in critical care

Venous thromboembolism following hematopoietic stem cell transplantation—a systematic review and meta-analysis

Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds

Suchergebnisse filtern